The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Carfilzomib, a second-generation proteasome inhibitor, to enhance the activity of ibrutinib in rituximab-chemotherapy sensitive or resistant B-cell lymphoma cell lines and primary patient samples.

Qunling  Zhang

No Relationships to Disclose

Juan J  Gu

No Relationships to Disclose

Cory  Mavis

No Relationships to Disclose

Ye  Guo

No Relationships to Disclose

Francisco J.  Hernandez-Ilizaliturri

No Relationships to Disclose

Myron Stefan  Czuczman

Honoraria - Mundipharma

Consulting or Advisory Role - Algeta ASA; Boehringer Ingelheim; Celgene; Gilead Sciences; Millennium; MorphoSys; Mundipharma; Teva; TG Therapeutics